The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2025

• Citation: S.I. 2025/749
• Sections: 22

Section 1 Citation, commencement, extent and application

(1) These Regulations may be cited as the Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2025.

(2) These Regulations come into force on the twenty-first day after the day on which they are made.

(3) Any amendment or omission made by these Regulations has the same extent and application as the provision amended or omitted, subject to paragraph (4).

(4) In Part 2—

(a) regulations 3, 5, 6 and 8 apply in relation to England and Wales and Scotland;

(b) regulations 4 and 7 apply in relation to Northern Ireland;

(c) regulations 11 and 12 extend and apply to England and Wales, Scotland and Northern Ireland.

Section 2 Amendment of the Medical Devices Regulations 2002

The Medical Devices Regulations 2002 are amended in accordance with regulations 3 to 12.

Section 3 Amendment of regulation 53 in relation to England, Scotland and Wales

In regulation 53 (fees in connection with the registration of devices and changes to registration details) , for “£240” substitute “£261” .

Section 4 Amendment of regulation 53 in relation to Northern Ireland

In regulation 53 (fees in connection with the registration of devices and changes to registration details) , for “£240” substitute “£261” .

Section 5 Amendment of regulation 54 in relation to England, Scotland and Wales

In regulation 54 (fees payable in connection with the designation of approved bodies) —

(a) in paragraph (1)—

(i) in sub-paragraph (a), for “£8,918” substitute “£10,335” ;

(ii) in sub-paragraph (b), for “£35,672” substitute “£41,337” ;

(b) in paragraph (2)—

(i) in sub-paragraph (a), for “£12,571” substitute “£14,568” ;

(ii) in sub-paragraph (b), for “£18,212” substitute “£21,105” ;

(c) in paragraph (3)—

(i) in sub-paragraph (a), for “£58,341” substitute “£67,606” ;

(ii) in sub-paragraph (b), for “£45,675” substitute “£52,929” ;

(iii) in sub-paragraph (c), for “£10,072” substitute “£11,672” ;

(d) in paragraph (3A)—

(i) in sub-paragraph (a)(i), for “£631” substitute “£732” ;

(ii) in sub-paragraph (a)(ii), for “£171” substitute “£198” ;

(e) in paragraph (3C)—

(i) in sub-paragraph (a), for “£35,672” substitute “£41,337” ;

(ii) in sub-paragraph (b), for “£58,341” substitute “£67,606” ;

(f) in paragraph (3D)—

(i) in sub-paragraph (a), for “£18,583” substitute “£21,535” ;

(ii) in sub-paragraph (b), for “£22,789” substitute “£26,408” ;

(g) in paragraph (3E), for “£1,297” substitute “£1,503” ;

(h) in paragraph (3F), for “£22,789” substitute “£26,408” .

Section 6 Amendment of regulation 55 in relation to England, Scotland and Wales

In regulation 55 (fees payable in connection with the designation etc. of conformity assessment bodies) —

(a) in paragraph (1)—

(i) in sub-paragraph (a), for “£8,918” substitute “£10,335” ;

(ii) in sub-paragraph (b), for “£35,672” substitute “£41,337” ;

(b) in paragraph (2)—

(i) in sub-paragraph (a), for “£12,571” substitute “£14,568” ;

(ii) in sub-paragraph (b), for “£18,212” substitute “£21,105” ;

(c) in paragraph (3)—

(i) in sub-paragraph (a), for “£58,341” substitute “£67,606” ;

(ii) in sub-paragraphs (b) and (d), for “£10,072” substitute “£11,672” ;

(d) in paragraph (3A), for “£58,341” substitute “£67,606” ;

(e) in paragraph (3B), for “£10,072” substitute “£11,672” ;

(f) in paragraph (3D)—

(i) in sub-paragraph (a)(i), for “£631” substitute “£732” ;

(ii) in sub-paragraph (a)(ii), for “£171” substitute “£198” .

Section 7 Amendment of regulation 55 in relation to Northern Ireland

In regulation 55 (fees payable in connection with the designation etc. of conformity assessment bodies) —

(a) in paragraph (1)—

(i) in sub-paragraph (a), for “£8,918” substitute “£10,335” ;

(ii) in sub-paragraph (b), for “£35,672” substitute “£41,337” ;

(b) in paragraph (2)—

(i) in sub-paragraph (a), for “£12,571” substitute “£14,568” ;

(ii) in sub-paragraph (b), for “£18,212” substitute “£21,105” ;

(c) in paragraph (3)—

(i) in sub-paragraph (a), for “£58,341” substitute “£67,606” ;

(ii) in sub-paragraphs (b) and (d), for “£10,072” substitute “£11,672” ;

(d) in paragraph (3A), for “£58,341” substitute “£67,606” ;

(e) in paragraph (3B), for “£10,072” substitute “£11,672” ;

(f) in paragraph (3D)—

(i) in sub-paragraph (a)(i), for “£631” substitute “£732” ;

(ii) in sub-paragraph (a)(ii), for “£171” substitute “£198” .

Section 8 Amendment of regulation 56 in relation to England, Scotland and Wales

In regulation 56 (fees payable in relation to clinical investigation notices) —

(a) in paragraph (1)—

(i) in sub-paragraph (a)(i), for “£5,711” substitute “£11,701” ;

(ii) in sub-paragraph (a)(ii), for “£11,069” substitute “£22,678” ;

(iii) in sub-paragraph (b)(i), for “£7,472” substitute “£15,309” ;

(iv) in sub-paragraph (b)(ii), for “£15,627” substitute “£32,016” ;

(b) in paragraph (3A)—

(i) in sub-paragraph (a), for “£207” substitute “£226” ;

(ii) in sub-paragraph (b), for “£331” substitute “£361” ;

(c) in paragraph (3B)—

(i) in sub-paragraph (a), for “£906” substitute “£987” ;

(ii) in sub-paragraph (b), for “£782” substitute “£852” .

Section 9 Amendment of regulation 56C

In regulation 56C (fees payable in connection with a consultation or further consultation on the safety, quality and usefulness of a medicinal substance incorporated in a device) —

(a) in paragraph (1)—

(i) in sub-paragraph (a), for “£4,550” substitute “£4,953” ;

(ii) in sub-paragraph (b), for “£10,604” substitute “£11,543” ;

(b) in paragraph (2)—

(i) in sub-paragraph (a), for “£900” substitute “£980” ;

(ii) in sub-paragraph (b), for “£2,451” substitute “£2,668” ;

(c) in paragraph (3)—

(i) in sub-paragraph (a), for “£46,526” substitute “£50,644” ;

(ii) in sub-paragraph (b), for “£11,551” substitute “£12,574” .

Section 10 Omission of regulation 56D

Omit regulation 56D (fees payable in connection with pre-consultation meetings) .

Section 11 New regulation 56E

Before regulation 57 (unpaid fees), insert—

Fees payable in connection with regulatory advice meetings

(56E)

(1) Unless regulation 56(3B)(a) applies, or regulation 17A(2)(a) of the Medical Devices (Northern Ireland Protocol) Regulations 2021 applies, the fee payable by a person with whom the Secretary of State holds a meeting in order to provide regulatory advice relating to a medical device is £987 for each hour that meeting takes.

(2) Any fee payable under this regulation must be paid within 14 days following written notice from the Secretary of State requiring payment of that fee.

Section 12 New regulation 58A

After regulation 58 (waivers, reductions and refunds), insert—

Time for payment of fees - small companies

(58A)

(1) Where a fee in regulation 56(1) is payable by a small company, if the small company so requests to the Secretary of State in writing, 50% of that fee shall be payable when the notice to which it relates is given to the Secretary of State and 50% of that fee shall be payable within six months of the date when the notice is given.

(2) For the purpose of this regulation, a company is a small company if, for the financial year before that in which the notice is given, the total value of products it has sold or supplied for the financial year is not more than the amount specified in item 1 in section 382(3) (qualification of company as small) of the Companies Act 2006 and either—

(a) the company’s balance sheet total as defined in section 382(5) of the Companies Act 2006 is not more than the amount specified in item 2 in section 382(3) of that Act; or

(b) the average number of persons employed by the company in the financial year before that in which the notice is given (determined on a weekly basis) does not exceed the number specified in item 3 in section 382(3) of that Act.

(3) In this regulation, a reference to section 382 of the Companies Act 2006 is a reference to that section as amended by the Companies (Accounts and Reports) (Amendment and Transitional Provision) Regulations 2024 .

Section 13 Amendment of the Blood Safety and Quality Regulations 2005

(1) Regulation 22 (fees) of the Blood Safety and Quality Regulations 2005 is amended as follows.

(2) In paragraph (2)—

(a) in sub-paragraph (b), for “£570” substitute “£621” ;

(b) in sub-paragraph (c), for “£509” substitute “£555” .

(3) In paragraph (2A)(b), for “£967” substitute “£1,053” .

(4) In paragraph (3)—

(a) in sub-paragraph (a), for “£3,552” substitute “£5,324” ;

(b) in sub-paragraph (b), for “£1,776” substitute “£2,662” .

(5) In paragraph (3A), for “£751” substitute “£818” .

(6) In paragraph (3C)(c), for “£967” substitute “£1,053” .

(7) In paragraph (5)—

(a) in sub-paragraph (a), for “£3,552” substitute “£5,324” ;

(b) in sub-paragraph (b), for “£1,776” substitute “£2,662” .

(8) In paragraph (5B)—

(a) in sub-paragraph (a), for “£3,552” substitute “£5,324” ;

(b) in sub-paragraph (b), for “£1,776” substitute “£2,662” .

(9) In paragraph (5C)—

(a) in sub-paragraph (a), for “£3,552” substitute “£5,324” ;

(b) in sub-paragraph (b), for “£1,776” substitute “£2,662” .

(10) In paragraph (5E), for “£11,000” substitute “£11,974” .

Section 14 Amendment of the Medical Devices (Northern Ireland Protocol) Regulations 2021

The Medical Devices (Northern Ireland Protocol) Regulations 2021 are amended in accordance with regulations 14 to 22.

Section 15 Amendment of regulation 7

In regulation 7(5) (registration of custom-made devices) , for “£240” substitute “£261” .

Section 16 Amendment of regulation 16

After regulation 16(4) (clinical investigation fees) , insert—

(4A) Where the relevant fee is payable pursuant to paragraph (1)(a) by a small company, if the small company so requests to the Secretary of State in writing, 50% of that fee shall be payable when the application to which it relates is submitted to the Secretary of State and 50% of that fee shall be payable within six months of the date on which the application was submitted.

(4B) For the purpose of this regulation, a company is a small company if, for the financial year before that in which the application or notification is submitted or given, the total value of products it has sold or supplied for the financial year is not more than the amount specified in item 1 in section 382(3) (qualification of company as small) of the Companies Act 2006 and either—

(a) the company’s balance sheet total as defined in section 382(5) of the Companies Act 2006 is not more than the amount specified in item 2 in section 382(3) of that Act; or

(b) the average number of persons employed by the company in the financial year before that in which the application or notice is submitted or given (determined on a weekly basis) does not exceed the number specified in item 3 in section 382(3) of that Act.

(4C) In this regulation, a reference to section 382 of the Companies Act 2006 is a reference to that section as amended by the Companies (Accounts and Reports) (Amendment and Transitional Provision) Regulations 2024 .

Section 17 Amendment of regulation 17A

In regulation 17A(2) (advice in relation to intended clinical investigations) —

(a) in sub-paragraph (a), for “£906” substitute “£987” ;

(b) in sub-paragraph (b), for “£782” substitute “£852” .

Section 18 Amendment of regulation 19

In regulation 19 (fees payable in connection with the designation of notified bodies) —

(a) in paragraph (3), for “£1,297” substitute “£1,503” ;

(b) in paragraph (6)—

(i) in sub-paragraph (b)(i), for “£631” substitute “£732” ;

(ii) in sub-paragraph (b)(ii), for “£171” substitute “£198” .

Section 19 Amendment of regulation 19C

In regulation 19C (fees payable in connection with a consultation or further consultation on the safety, quality and usefulness of a medicinal substance incorporated in a device) —

(a) in paragraph (1)—

(i) in sub-paragraph (a), for “£4,550” substitute “£4,953” ;

(ii) in sub-paragraph (b), for “£10,604” substitute “£11,543” ;

(b) in paragraph (2)—

(i) in sub-paragraph (a), for “£900” substitute “£980” ;

(ii) in sub-paragraph (b), for “£2,451” substitute “£2,668” ;

(c) in paragraph (3)—

(i) in sub-paragraph (a), for “£46,526” substitute “£50,644” ;

(ii) in sub-paragraph (b), for “£11,551” substitute “£12,574” .

Section 20 Omission of regulation 19D

Omit regulation 19D (fees for pre-consultation meetings) .

Section 21 Amendment of Schedule 1

(1) Schedule 1 (fees for clinical investigations) is amended as follows.

(2) In Table 1 (clinical investigation of a class I device, class IIa device or class IIb device, which is neither an implantable device nor a long-term invasive device), in the second column (fee)—

(a) in entry 1, for “£7,472” substitute “£15,309” ;

(b) in entry 2, for “£5,711” substitute “£11,701” ;

(c) in entry 3, for “£207” substitute “£226” .

(3) In Table 2 (clinical investigation of a class IIb device, which is either an implantable device or a long-term invasive device, or a class III device), in the second column (fee)—

(a) in entry 1, for “£15,627” substitute “£32,016” ;

(b) in entry 2, for “£11,069” substitute “£22,678” ;

(c) in entry 3, for “£331” substitute “£361” .

Section 22 Amendment of Schedule 2

(1) Schedule 2 (fees in connection with the designation of notified bodies) is amended as follows.

(2) In Table 1 (application fees), in the second column (fee)—

(a) in entry 1, for “£35,672” substitute “£41,337” ;

(b) in entry 2, for “£8,918” substitute “£10,335” ;

(c) in entry 3, for “£35,672” substitute “£41,337” ;

(d) in entry 4, for “£12,571” substitute “£14,568” ;

(e) in entry 5, for “£18,212” substitute “£21,105” .

(3) In Table 2 (fees for assessments and reviews), in the second column (fee)—

(a) in entry 1, for “£58,341” substitute “£67,606” ;

(b) in entry 2, for “£45,675” substitute “£52,929” ;

(c) in entry 3, for “£10,072” substitute “£11,672” ;

(d) in entry 4, for “£22,789” substitute “£26,408” ;

(e) in entry 5—

(i) in sub-paragraph (a), for “£18,583” substitute “£21,535” ;

(ii) in sub-paragraph (b), for “£22,789” substitute “£26,408” .